MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations

Laura Farina, Luisa Chiapparini, Graziella Uziel, Marianna Bugiani, Massimo Zeviani, Mario Savoiardo

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: In a large number of patients with Leigh syndrome (LS) and cytochrome c oxidase (COX) deficiency, mutations of the SURF-1 gene were recently identified. The aim of the present study was to review the MR findings in patients with LS to verify if the genetically homogeneous patients with LS and SURF-1 mutations (LS SURF-1 patients) had a homogeneous MR pattern that could be used to differentiate them from other patients with LS (LS non-SURF-1 patients). METHODS: T1-, proton density-, and T2-weighted MR images of eight LS SURF-1 patients and 14 LS non-SURF-1 patients were reviewed. Enzymatic activity was determined according to standard methods. Genetic analysis was mostly performed by using stored DNA samples. RESULTS: All LS SURF-1 patients had lesions in the brain stem and subthalamic nuclei. Six had lesions in the cerebellum. Only two had basal ganglial abnormalities. Ten LS non-SURF-1 patients had lesions in the brain stem, but in six they were mild. Ten patients had basal ganglial abnormalities (nine of 10 in the putamina). LS-SURF-1 patients had a more severe clinical course. CONCLUSION: The MR pattern in LS SURF-1 patients is characteristic. Brain stem and subthalamic nuclei lesions may suggest the specific diagnosis. These patients die soon, probably because of lower brain stem involvement. Basal ganglial abnormalities are common only in LS non-SURF-1 patients. The absence of putaminal lesions, therefore, does not exclude the diagnosis of LS.

Original languageEnglish
Pages (from-to)1095-1100
Number of pages6
JournalAmerican Journal of Neuroradiology
Volume23
Issue number7
Publication statusPublished - Aug 2002

Fingerprint

Leigh Disease
Oxidoreductases
Mutation
Brain Stem
Subthalamic Nucleus
Cytochrome-c Oxidase Deficiency

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. / Farina, Laura; Chiapparini, Luisa; Uziel, Graziella; Bugiani, Marianna; Zeviani, Massimo; Savoiardo, Mario.

In: American Journal of Neuroradiology, Vol. 23, No. 7, 08.2002, p. 1095-1100.

Research output: Contribution to journalArticle

Farina, L, Chiapparini, L, Uziel, G, Bugiani, M, Zeviani, M & Savoiardo, M 2002, 'MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations', American Journal of Neuroradiology, vol. 23, no. 7, pp. 1095-1100.
Farina, Laura ; Chiapparini, Luisa ; Uziel, Graziella ; Bugiani, Marianna ; Zeviani, Massimo ; Savoiardo, Mario. / MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. In: American Journal of Neuroradiology. 2002 ; Vol. 23, No. 7. pp. 1095-1100.
@article{d42e65ae557c45c3be80cd2ac39e42c7,
title = "MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations",
abstract = "BACKGROUND AND PURPOSE: In a large number of patients with Leigh syndrome (LS) and cytochrome c oxidase (COX) deficiency, mutations of the SURF-1 gene were recently identified. The aim of the present study was to review the MR findings in patients with LS to verify if the genetically homogeneous patients with LS and SURF-1 mutations (LS SURF-1 patients) had a homogeneous MR pattern that could be used to differentiate them from other patients with LS (LS non-SURF-1 patients). METHODS: T1-, proton density-, and T2-weighted MR images of eight LS SURF-1 patients and 14 LS non-SURF-1 patients were reviewed. Enzymatic activity was determined according to standard methods. Genetic analysis was mostly performed by using stored DNA samples. RESULTS: All LS SURF-1 patients had lesions in the brain stem and subthalamic nuclei. Six had lesions in the cerebellum. Only two had basal ganglial abnormalities. Ten LS non-SURF-1 patients had lesions in the brain stem, but in six they were mild. Ten patients had basal ganglial abnormalities (nine of 10 in the putamina). LS-SURF-1 patients had a more severe clinical course. CONCLUSION: The MR pattern in LS SURF-1 patients is characteristic. Brain stem and subthalamic nuclei lesions may suggest the specific diagnosis. These patients die soon, probably because of lower brain stem involvement. Basal ganglial abnormalities are common only in LS non-SURF-1 patients. The absence of putaminal lesions, therefore, does not exclude the diagnosis of LS.",
author = "Laura Farina and Luisa Chiapparini and Graziella Uziel and Marianna Bugiani and Massimo Zeviani and Mario Savoiardo",
year = "2002",
month = "8",
language = "English",
volume = "23",
pages = "1095--1100",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "7",

}

TY - JOUR

T1 - MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations

AU - Farina, Laura

AU - Chiapparini, Luisa

AU - Uziel, Graziella

AU - Bugiani, Marianna

AU - Zeviani, Massimo

AU - Savoiardo, Mario

PY - 2002/8

Y1 - 2002/8

N2 - BACKGROUND AND PURPOSE: In a large number of patients with Leigh syndrome (LS) and cytochrome c oxidase (COX) deficiency, mutations of the SURF-1 gene were recently identified. The aim of the present study was to review the MR findings in patients with LS to verify if the genetically homogeneous patients with LS and SURF-1 mutations (LS SURF-1 patients) had a homogeneous MR pattern that could be used to differentiate them from other patients with LS (LS non-SURF-1 patients). METHODS: T1-, proton density-, and T2-weighted MR images of eight LS SURF-1 patients and 14 LS non-SURF-1 patients were reviewed. Enzymatic activity was determined according to standard methods. Genetic analysis was mostly performed by using stored DNA samples. RESULTS: All LS SURF-1 patients had lesions in the brain stem and subthalamic nuclei. Six had lesions in the cerebellum. Only two had basal ganglial abnormalities. Ten LS non-SURF-1 patients had lesions in the brain stem, but in six they were mild. Ten patients had basal ganglial abnormalities (nine of 10 in the putamina). LS-SURF-1 patients had a more severe clinical course. CONCLUSION: The MR pattern in LS SURF-1 patients is characteristic. Brain stem and subthalamic nuclei lesions may suggest the specific diagnosis. These patients die soon, probably because of lower brain stem involvement. Basal ganglial abnormalities are common only in LS non-SURF-1 patients. The absence of putaminal lesions, therefore, does not exclude the diagnosis of LS.

AB - BACKGROUND AND PURPOSE: In a large number of patients with Leigh syndrome (LS) and cytochrome c oxidase (COX) deficiency, mutations of the SURF-1 gene were recently identified. The aim of the present study was to review the MR findings in patients with LS to verify if the genetically homogeneous patients with LS and SURF-1 mutations (LS SURF-1 patients) had a homogeneous MR pattern that could be used to differentiate them from other patients with LS (LS non-SURF-1 patients). METHODS: T1-, proton density-, and T2-weighted MR images of eight LS SURF-1 patients and 14 LS non-SURF-1 patients were reviewed. Enzymatic activity was determined according to standard methods. Genetic analysis was mostly performed by using stored DNA samples. RESULTS: All LS SURF-1 patients had lesions in the brain stem and subthalamic nuclei. Six had lesions in the cerebellum. Only two had basal ganglial abnormalities. Ten LS non-SURF-1 patients had lesions in the brain stem, but in six they were mild. Ten patients had basal ganglial abnormalities (nine of 10 in the putamina). LS-SURF-1 patients had a more severe clinical course. CONCLUSION: The MR pattern in LS SURF-1 patients is characteristic. Brain stem and subthalamic nuclei lesions may suggest the specific diagnosis. These patients die soon, probably because of lower brain stem involvement. Basal ganglial abnormalities are common only in LS non-SURF-1 patients. The absence of putaminal lesions, therefore, does not exclude the diagnosis of LS.

UR - http://www.scopus.com/inward/record.url?scp=0036677381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036677381&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 1095

EP - 1100

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 7

ER -